molnupiravir Archives - Page 2 of 5 - Express Pharma

Biophore receives sub-licence from MPP to manufacture and market Molnupiravir

Fermenta Biotech licenses its proprietary enzymatic technology for manufacturing Molnupiravir to Aurigene Pharma

Merck allocates three million courses of Molnupiravir to be provided in first half of 2022 for use in LMICs

ICMR refuses using Molnupiravir for COVID treatment, pulmonologists disagree

MSN to launch generic anti-COVID pill Molnupiravir under ‘Molulow’ brand

Aurobindo Pharma rolls out Molnaflu to treat adult COVID-19 patients

Pfizer to supply US with 10 million more courses of COVID-19 pills

Dr Reddy’s to launch generic COVID-19 Merck drug at about 50 cents a pill

Emcure Pharmaceuticals to launch oral COVID-19 drug in a week’s time in India

Briton Pharma’s anti-COVID drug Molviton to hit Indian market next week